CCM
Camber Capital Management Portfolio holdings
AUM
$718M
This Quarter Return
-11.05%
1 Year Return
-4.23%
3 Year Return
+26.63%
5 Year Return
+47.71%
10 Year Return
+121.3%
AUM
$2.3B
AUM Growth
+$2.3B
(-17%)
Cap. Flow
-$177M
Cap. Flow
% of AUM
-7.7%
Top 10 Holdings %
Top 10 Hldgs %
58.87%
Holding
47
New
10
Increased
12
Reduced
5
Closed
7
Top Buys
| 1 |
Select Medical
SEM
|
$70.9M |
| 2 |
Tenet Healthcare
THC
|
$51.2M |
| 3 |
Dentsply Sirona
XRAY
|
$44.7M |
| 4 |
Sarepta Therapeutics
SRPT
|
$35.6M |
| 5 |
Exelixis
EXEL
|
$28.1M |
Top Sells
| 1 |
Gilead Sciences
GILD
|
$149M |
| 2 |
Merck
MRK
|
$123M |
| 3 |
Universal Health Services
UHS
|
$86.1M |
| 4 |
CHNG
Change Healthcare Inc. Common Stock
CHNG
|
$84.7M |
| 5 |
Medtronic
MDT
|
$55.5M |
Sector Composition
| 1 | Healthcare | 97.09% |
| 2 | Technology | 2.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Teva Pharmaceuticals
TEVA
$21.1B
| $20.7M | 0.9% | 2,750,000 | – | – |
|
27
Inogen
INGN
$216M
| $19.9M | 0.87% | 825,000 +75,000 | +10% | +$1.81M |
|
28
Collegium Pharmaceutical
COLL
$1.22B
| $18.6M | 0.81% | 1,050,000 | – | – |
|
29
Quanterix
QTRX
$211M
| $18.5M | 0.8% | +1,141,700 | New | +$18.5M |
|
|
CSII
30
DELISTED
Cardiovascular Systems, Inc.
CSII
| $13.5M | 0.59% | +940,400 | New | +$13.5M |
|
|
CANO
31
DELISTED
Cano Health, Inc.
CANO
| $13.1M | 0.57% | +3,000,000 | New | +$13.1M |
|
32
Puma Biotechnology
PBYI
$254M
| $12.1M | 0.52% | 4,235,000 +235,000 | +6% | +$670K |
|
33
Exact Sciences
EXAS
$8.98B
| $11.8M | 0.51% | +300,000 | New | +$11.8M |
|
34
OraSure Technologies
OSUR
$242M
| $11.5M | 0.5% | 4,250,000 | – | – |
|
|
NSTG
35
DELISTED
NanoString Technologies, Inc.
NSTG
| $10.8M | 0.47% | +850,000 | New | +$10.8M |
|
36
Zymeworks
ZYME
$1.12B
| $10.6M | 0.46% | 2,000,000 | – | – |
|
37
Glaukos
GKOS
$5.5B
| $8.5M | 0.37% | 187,022 | – | – |
|
38
Pacific Biosciences
PACB
$393M
| $1.88M | 0.08% | +424,600 | New | +$1.88M |
|
|
SDC
39
DELISTED
SmileDirectClub, Inc. Class A Common Stock
SDC
| $1.04M | 0.05% | 1,000,000 | – | – |
|
|
TSVT
40
DELISTED
2seventy bio
TSVT
| $642K | 0.03% | +48,600 | New | +$642K |
|
|
41
Gilead Sciences
GILD
$140B
| – | – | -2,500,000 | Closed | -$149M |
|
42
GSK
GSK
$79.9B
| – | – | -1,000,000 | Closed | -$43.6M |
|
|
43
Medtronic
MDT
$119B
| – | – | -500,000 | Closed | -$55.5M |
|
|
44
Merck
MRK
$210B
| – | – | -1,500,000 | Closed | -$123M |
|
45
Neurocrine Biosciences
NBIX
$13.8B
| – | – | -300,000 | Closed | -$28.1M |
|
46
Nektar Therapeutics
NKTR
$568M
| – | – | -4,000,000 | Closed | -$21.6M |
|
|
RDUS
47
DELISTED
Radius Health, Inc.
RDUS
| – | – | -262,900 | Closed | -$2.32M |
|